DIAVACS
The company potentially addresses the disadvantages of prior approaches by offering local antigen-specific immunosuppression, halting the pathogenic autoimmune response without compromising the body's immune system, and complements emerging regenerative approaches by protecting newly created beta cells from autoimmune attack, enabling patients to get rid from lifelong dependency on insulin.
DIAVACS
Industry:
Biotechnology Health Diagnostics Therapeutics
Founded:
2013-01-01
Address:
Edgewater, New Jersey, United States
Country:
United States
Total Employee:
51+
Status:
Active
Total Funding:
850 K USD
Technology used in webpage:
OpenResty
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Advisors List
Current Employees Featured
Founder